Table 3.
AEs occurring in >10% of treated patients irrespective of causality.
| MedDRA preferred term, n (%) | All patients (n = 31) | |
|---|---|---|
| All grades | Grade ≥3 | |
| Patients with any AE | 31 (100) | 17 (55) |
| Diarrhea | 21 (68) | 2 (6) |
| Nausea | 14 (45) | 1 (3) |
| Headache | 9 (29) | 2 (6) |
| Vomiting | 9 (29) | 1 (3) |
| Dizziness | 7 (23) | 0 |
| Fatigue | 7 (23) | 0 |
| Abdominal pain | 5 (16) | 1 (3) |
| Constipation | 5 (16) | 0 |
| Hyperglycemia | 5 (16) | 1 (3) |
| Rash maculopapular | 5 (16) | 3 (10) |
| Decreased appetite | 4 (13) | 0 |
| Flatulence | 4 (13) | 0 |
| Pruritus | 4 (13) | 0 |
AE adverse event, MedDRA Medical Dictionary for Regulatory Activities.